tiprankstipranks
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress ReleasesRigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2M ago
Rigel Pharmaceuticals reports Q4 EPS 0c, consensus (3c)
PremiumThe Fly
Rigel Pharmaceuticals reports Q4 EPS 0c, consensus (3c)
2M ago
Options Volatility and Implied Earnings Moves Today, March 05, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 05, 2024
2M ago
Rigel Pharmaceuticals acquires U.S. rights to Gavreto
PremiumThe FlyRigel Pharmaceuticals acquires U.S. rights to Gavreto
2M ago
Rigel Pharmaceuticals sees Q4 revenue $35.7M, consensus $29.78M
PremiumThe Fly
Rigel Pharmaceuticals sees Q4 revenue $35.7M, consensus $29.78M
4M ago
Rigel Pharmaceuticals collaborating with Connect network in Phase 2 glioma trial
PremiumThe Fly
Rigel Pharmaceuticals collaborating with Connect network in Phase 2 glioma trial
4M ago
Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress ReleasesRigel Reports Third Quarter 2023 Financial Results and Provides Business Update
6M ago
Rigel Pharmaceuticals reports Q3 EPS (3c), consensus (7c)
PremiumThe Fly
Rigel Pharmaceuticals reports Q3 EPS (3c), consensus (7c)
6M ago
Is RIGL a Buy, Before Earnings?
PremiumPre-Earnings
Is RIGL a Buy, Before Earnings?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100